These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20047614)

  • 41. Differential gene expression profiles in the steatosis/fibrosis model of rat liver by chronic administration of carbon tetrachloride.
    Chung H; Hong DP; Kim HJ; Jang KS; Shin DM; Ahn JI; Lee YS; Kong G
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):242-54. PubMed ID: 16239168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice.
    Ishikawa T; Terai S; Urata Y; Marumoto Y; Aoyama K; Murata T; Mizunaga Y; Yamamoto N; Nishina H; Shinoda K; Sakaida I
    Cell Tissue Res; 2007 Mar; 327(3):463-70. PubMed ID: 17093919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.
    Salama H; Zekri AR; Zern M; Bahnassy A; Loutfy S; Shalaby S; Vigen C; Burke W; Mostafa M; Medhat E; Alfi O; Huttinger E
    Cell Transplant; 2010; 19(11):1475-86. PubMed ID: 20587151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation.
    Drewa T; Joachimiak R; Kaznica A; Flisinski M; Brymora A; Manitius J
    Transplant Proc; 2008 Jun; 40(5):1668-73. PubMed ID: 18589170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of interferon alpha on the rat liver injured by chronic administration of carbon tetrachloride.
    Madro A; Słomka M; Celiński K; Chibowski D; Czechowska G; Kleinrok Z; Karpińska A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):55-60. PubMed ID: 12898905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autologous bone marrow cell infusion therapy for liver cirrhosis patients.
    Terai S; Sakaida I
    J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):23-5. PubMed ID: 20632039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema.
    Miquel M; Bartolí R; Odena G; Serafín A; Cabré E; Galan A; Barba I; Córdoba J; Planas R
    Liver Int; 2010 Aug; 30(7):979-87. PubMed ID: 20492509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intrahepatic transplantation of in vitro induced autologous bone marrow-derived liver stem cells in patients with posthepatitic cirrhosis].
    Qin AC; Liao CX; Wang Y; Yuan J; Huang YP; Lia XX; Lai YQ; Gong ZY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):529-1. PubMed ID: 20335128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations of bone marrow sinusoidal endothelium in rat and patients with liver cirrhosis.
    Zhao S; Fu YM; Li XF; Jin ZF; Zhao RB; Huang Q; Zhang FM; Zhang WH
    Dig Dis Sci; 2010 Mar; 55(3):654-61. PubMed ID: 19333758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute-on-chronic liver failure: the heart and systemic hemodynamics.
    Liu H; Lee SS
    Curr Opin Crit Care; 2011 Apr; 17(2):190-4. PubMed ID: 21326096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Research development of bone marrow stem cells for chronic liver failure treatment].
    Yang F; Qin B
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):795-7. PubMed ID: 21059304
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of liver fibrosis using Raman spectroscopy and infrared thermography: A pilot study.
    Ramírez-Elías MG; Kolosovas-Machuca ES; Kershenobich D; Guzmán C; Escobedo G; González FJ
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():278-283. PubMed ID: 28754542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute-on chronic liver failure.
    Jalan R; Gines P; Olson JC; Mookerjee RP; Moreau R; Garcia-Tsao G; Arroyo V; Kamath PS
    J Hepatol; 2012 Dec; 57(6):1336-48. PubMed ID: 22750750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical application of bone marrow cell transplantation for liver diseases.
    Sakaida I
    J Gastroenterol; 2006 Jan; 41(1):93-4. PubMed ID: 16501866
    [No Abstract]   [Full Text] [Related]  

  • 55. Acute-on-chronic liver failure: from concept to a new syndrome.
    Jalan R
    Curr Opin Crit Care; 2011 Apr; 17(2):152. PubMed ID: 21358404
    [No Abstract]   [Full Text] [Related]  

  • 56. Palliative care in patients with liver cirrhosis: it is the time to deal with the burden.
    Lisotti A; Fusaroli P; Caletti G
    BMJ Support Palliat Care; 2015 Dec; 5(5):466-7. PubMed ID: 26124513
    [No Abstract]   [Full Text] [Related]  

  • 57. [Role of immunodepressors and immunonormalizers in the genesis of liver fibrosis and cirrhosis].
    Shalimov VA
    Klin Khir (1962); 1979 Nov; (11):29-33. PubMed ID: 513521
    [No Abstract]   [Full Text] [Related]  

  • 58. Is periodontitis a risk factor for infections in cirrhotic patients?
    Di Profio B; Villar CC; Saraiva L; Ortega KL; Pannuti CM
    Med Hypotheses; 2017 Sep; 106():19-22. PubMed ID: 28818265
    [No Abstract]   [Full Text] [Related]  

  • 59. A chronic disease management model for chronic liver failure.
    Wigg AJ; Chinnaratha MA; Wundke R; Volk ML
    Hepatology; 2015 Feb; 61(2):725-8. PubMed ID: 24677213
    [No Abstract]   [Full Text] [Related]  

  • 60. Can chronic disease management programs improve outcomes in patients with cirrhosis?
    Mayorga CA; Singal AG
    Gastroenterology; 2013 Nov; 145(5):1153-5. PubMed ID: 24055092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.